NEAT1-Mediated Intestinal Barrier Dysfunction Through miR-29b-3p Binding in Lipopolysaccharide-Damaged Caco-2 Cells
Journal of Visualized Experiments · 2026
DOI: 10.3791/71021 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2026. Written by ShuMin Jiang and 6 co-authors. Institution: Department of Internal Medicine, Heyuan Street Community Healthcare Center of Heilongjiang Province Daqing City Datong District. Major MEDLINE topics: MicroRNAs, Irritable Bowel Syndrome, Intestinal Mucosa.
Abstract (original language)
The pathogenesis of irritable bowel syndrome with diarrhea (IBS-D) is unclear, and available therapies remain limited. This study evaluated the diagnostic value of NEAT1 in IBS-D and explored its potential regulatory mechanism. A total of 116 patients with IBS-D and 116 healthy controls were included. Serum NEAT1 and miR-29b-3p levels were detected by reverse transcription quantitative real-time PCR (RT-qPCR), and receiver operating characteristic (ROC) curves were used to evaluate diagnostic value. For mechanistic studies, a lipopolysaccharide (LPS)-treated Caco-2 intestinal epithelial cell model was established. Cell viability was assessed by Cell Counting Kit-8 (CCK-8) assay, apoptosis by flow cytometry, barrier integrity by transepithelial electrical resistance (TEER), and mRNA levels of ZO-1, occludin, and claudin-2 by RT-qPCR. Dual-luciferase reporter (DLR) and RNA immunoprecipitation (RIP) assays were used to verify the binding relationship between NEAT1 and miR-29b-3p. NEAT1 was highly expressed, and miR-29b-3p was lowly expressed in patients with IBS-D, and their levels showed a strong negative correlation. NEAT1 knockdown increased miR-29b-3p levels, enhanced cell viability and TEER, reduced apoptosis, increased ZO-1 and occludin mRNA levels, decreased claudin-2 mRNA levels, and alleviated barrier injury-associated readouts in LPS-treated Caco-2 cells. Together, these results indicate that serum NEAT1 is a candidate biomarker for IBS-D and that the NEAT1/miR-29b-3p axis may be involved in intestinal barrier dysfunction.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Internal Medicine, Heyuan Street Community Healthcare Center of Heilongjiang Province Daqing City Datong District.
- Department of Gastroenterology, The Second Hospital of Hebei Medical University.
- Department of Gastroenterology, Shanghai Pudong New Area People's Hospital.
- Department of organ Transplantation, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital; Gaoyaya_gyy@163.com.
Cite
APA
Jiang, S., Ping, C., He, X., Chen, G., Feng, L., Ji, J., & Gao, Y. (2026). NEAT1-Mediated Intestinal Barrier Dysfunction Through miR-29b-3p Binding in Lipopolysaccharide-Damaged Caco-2 Cells. Journal of Visualized Experiments. https://doi.org/10.3791/71021
Vancouver
Jiang S, Ping C, He X, Chen G, Feng L, Ji J, et al. NEAT1-Mediated Intestinal Barrier Dysfunction Through miR-29b-3p Binding in Lipopolysaccharide-Damaged Caco-2 Cells. Journal of Visualized Experiments. 2026. doi:10.3791/71021
BibTeX
@article{Jiang2026,
author = {Jiang, ShuMin and Ping, Chunrong and He, Xiaotong and Chen, Guoyu and Feng, Lingmei and Ji, Jieru and Gao, Yaya},
title = {NEAT1-Mediated Intestinal Barrier Dysfunction Through miR-29b-3p Binding in Lipopolysaccharide-Damaged Caco-2 Cells},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/71021}
}
EUVIMED